The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Aristolochic acid-associated urothelial cancer in Taiwan
Open accessAbstract
Aristolochic acid, a potent human carcinogen produced by Aristolochia plants, is associated with urothelial carcinoma of the upper urinary tract (UUC). Following metabolic activation, aristolochic acid reacts with DNA to form aristolactam (AL)-DNA adducts. These lesions concentrate in the renal cortex, where they serve as a sensitive and specific biomarker of exposure, and are found also in the urothelium, where they give rise to a unique mutational signature in the TP53 tumor-suppressor gene. Using AL-DNA adducts and TP53 mutation spectra as biomarkers, we conducted a molecular epidemiologic study of UUC in Taiwan, where the incidence of UUC is the highest reported anywhere in the world and where Aristolochia herbal remedies have been used extensively for many years. Our study involves 151 UUC patients, with 25 patients with renal cell carcinomas serving as a control group. The TP53 mutational signature in patients with UUC, dominated by otherwise rare A:T to T:A transversions, is identical to that observed in UUC associated with Balkan endemic nephropathy, an environmental disease. Prominent TP53 mutational hotspots include the adenine bases of 5′ AG (acceptor) splice sites located almost exclusively on the nontranscribed strand. A:T to T:A mutations also were detected at activating positions in the FGFR3 and HRAS oncogenes. AL-DNA adducts were present in the renal cortex of 83% of patients with A:T to T:A mutations in TP53 , FGFR3 , or HRAS . We conclude that exposure to aristolochic acid contributes significantly to the incidence of UUC in Taiwan, a finding with significant implications for global public health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Shepard, T. H. (1981) · Teratology · doi:10.1002/tera.1420230118 · Cited by 1,296
The IARC TP53 database: new online mutation analysis and recommendations to users
Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., & Hainaut, P. (2002) · Human Mutation · doi:10.1002/humu.10081 · Cited by 1,248
Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)
Nortier, J. L., Martinez, M.-C. M., Schmeiser, H. H., Arlt, V. M., Bieler, C. A., Petein, M., Depierreux, M. F., De Pauw, L., Abramowicz, D., Vereerstraeten, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006083422301 · Cited by 983
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974 · cited 1×
“Alternatively, AA could induce UUC via mutations in genes such as RB, a tumor-suppressor gene that is frequently inactivated in invasive urothelial carcinomas (24, 25).”
BackgroundUROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI )
Ortier, L. N., Arie, M., Chmeiser, H. S., Rlt, V. O. M. A., Ieler, H. A. B., Etein, M. I. P., Epierreux, M. I. F. D., Auw, L., Bramowicz, D. A. A., & Ereerstraeten, P. I. V. (2014) · Cited by 814
Aristolochic acid nephropathy: A worldwide problem
Debelle, F. D., Vanherweghem, J.-L., & Nortier, J. L. (2008) · Kidney International · doi:10.1038/ki.2008.129 · Cited by 763
Urothelial tumorigenesis: a tale of divergent pathways
Wu, X.-R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1697 · Cited by 692
Self-citationAristolochic acid and the etiology of endemic (Balkan) nephropathy
Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701248104 · Cited by 606
Self-citationAristolochic acid as a probable human cancer hazard in herbal remedies: a review
Arlt, V. M. (2002) · Mutagenesis · doi:10.1093/mutage/17.4.265 · Cited by 505
Kompier, L. C., Lurkin, I., van der Aa, M. N. M., van Rhijn, B. W. G., van der Kwast, T. H., & Zwarthoff, E. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013821 · Cited by 315
Colin, P., Koenig, P., Ouzzane, A., Berthon, N., Villers, A., Biserte, J., & Rouprêt, M. (2009) · BJU International · doi:10.1111/j.1464-410x.2009.08838.x · Cited by 300
Lai, M.-N., Wang, S.-M., Chen, P.-C., Chen, Y.-Y., & Wang, J.-D. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp467 · Cited by 235
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
Jelaković, B., Karanović, S., Vuković-Lela, I., Miller, F., Edwards, K. L., Nikolić, J., Tomić, K., Slade, N., Brdar, B., Turesky, R. J., et al. (2012) · Kidney International · doi:10.1038/ki.2011.371 · Cited by 216
Self-citationChen, C., Chiou, H., Hsu, L.-I., Hsueh, Y., Wu, M., Wang, Y., & Chen, C. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0333 · Cited by 150
Self-citationSidorenko, V. S., Yeo, J.-E., Bonala, R., Johnson, F., Schärer, O. D., & Grollman, A. P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1095 · Cited by 110
Self-citationTP53 Mutational signature for aristolochic acid: an environmental carcinogen
Moriya, M., Slade, N., Brdar, B., Medverec, Z., Tomić, K., Jelaković, B., Wu, L., Truong, S., Fernandes, A., & Grollman, A. P. (2011) · International Journal of Cancer · doi:10.1002/ijc.26077 · Cited by 106
Self-citationLai, M., Lai, J., Chen, P., Hsieh, S.-C., Hu, F.-C., & Wang, J. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.10.055 · Cited by 96
Wu, K. M., Farrelly, J. G., Upton, R., & Chen, J. (2006) · Phytomedicine · doi:10.1016/j.phymed.2006.05.009 · Cited by 89
p53 and retinoblastoma pathways in bladder cancer
Mitra, A. P., Birkhahn, M., & Côté, R. J. (2007) · World Journal of Urology · doi:10.1007/s00345-007-0197-0 · Cited by 84
Nedelko, T., Arlt, V. M., Phillips, D. H., & Hollstein, M. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.24006 · Cited by 82
Lukin, M., Zaliznyak, T., Johnson, F., & Santos, C. D. L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1094 · Cited by 47
Chapter 7 Aristolochic Acid Nephropathy
Grollman, A. P., Scarborough, J., & Jelaković, B. (2009) · Advances in molecular toxicology · doi:10.1016/s1872-0854(09)00007-1 · Cited by 44
Self-citationClinical Nephrotoxins: Renal Injury from Drugs and Chemicals
Broe, M. E. D., Verpooten, G. A., Bennett, W. M., & Porter, G. A. (2003) · Springer eBooks · doi:10.1007/1-4020-2586-6 · Cited by 34
Morange, M. (2005) · Journal of Biosciences · doi:10.1007/bf02703668 · Cited by 30
Cited by
Ekor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919
“Chinese herbs nephropathy in the Kansai area: a warning report. Nihon Jinzo Gakkai Shi 39, 438–440. U.S. Food and Drug Administration. (2002). Kava-Containing Dietary Supple-”
BackgroundThe pharmaceutical industry and natural products: historical status and new trends
David, B., Wolfender, J.-L., & Dias, D. A. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-014-9367-z · Cited by 579
Manzetti, S., & Lu, T. (2013) · Journal of Physical Organic Chemistry · doi:10.1002/poc.3111 · Cited by 571
Yoshimoto, F. K. (2020) · The Protein Journal · doi:10.1007/s10930-020-09901-4 · Cited by 543
Soria, F., Shariat, S. F., Lerner, S. P., Fritsche, H.-M., Rink, M., Kassouf, W., Spiess, P. E., Lotan, Y., Ye, D., Fernández, M. I., et al. (2017) · World Journal of Urology · doi:10.1007/s00345-016-1928-x · Cited by 465
Self-citation
Metadata
- Authors
- Chen, C.-H., Dickman, K. G., Moriya, M., Zavadil, J., Sidorenko, V. S., Edwards, K. L., Gnatenko, D. V., Wu, L., Turesky, R. J., Wu, X.-R., Pu, Y.-S., & Grollman, A. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-04-09
- Volume
- 109
- Issue
- 21
- Pages
- 8241-8246
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2082312233
- Cited by
- 419
- References
- 27
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.